This lists all the documents/websites relevant to the guideline that are available on the IHE and TOP websites, both clinician and patient resources. Link to Alberta Ambassador Guideline Adaptation Program
- Chronic Diseases / Disorders
- Fetal Alcohol Spectrum Disorder (FASD)
- Health Economics / Healthcare Costs
- Health Measurement Tools
- Health Policy
- Healthcare Services
- Infectious Diseases
- Maternal and Child Health
- Mental Health
- Quality of Life
The outcome of IHE initiatives is providing better information for developing health policy and best medical practices. IHE disseminates information in many ways. In addition to publications in peer-reviewed journals, IHE produces books and a variety of reports synthesizing information in a particular field.
Filter your search by clicking filters to the left.
This report provides a summary of the IHE Real-World Evidence Roundtable, which took place on December 12, 2016. The intent of the roundtable was to capture initial thinking regarding preferences and perceptions of the use of real-world evidence for pricing and reimbursement of new medicines in Canada and what more may be needed.
This report provides a summary of the IHE Biosimilars Forum engagement exercise that took place on April 23, 2017 in Ottawa, Ontario. The intent of the forum was to identify: options to categorize and consider biosimilars; a process to engage stakeholders to identify place in therapy and further evidence development that may be required; and an approach to knowledge exchange that…
IHE In Your Pocket 2017 – A Handbook of Health Economic Statistics includes the most currently available data, presented in separate sections on the economic burden of illness, health care resources, health behaviours, health status and demographics, and health system performance. IHE In Your Pocket was designed to provide a compact, comprehensive, and comparative overview…
Adding universal rectal screening to urogenital screening should positively impact rectal Chlamydia trachomatis (CT) incidence in affected populations. A dynamic Markov model was used to evaluate costs and outcomes of three rectal CT screening strategies among women attending sexually transmitted infection clinics in Alberta, Canada: universal urogenital-only screening (UG-only),…
Building a Community-Based Health System: Lessons for a Path Forward is the 17th IHE Innovation Forum, a semi-annual event bringing together senior public- and private-sector experts and decision-makers to address health care policy issues.
PDF of a PowerPoint presentation by Dr. Muhamad Elrashidi, Kern Center Population Health Scholar, Mayo Clinic. IHE Innovation Forum XVII – Building a Community-Based Health System: Lessons for a Path Forward
PDF of a PowerPoint presentation by Mr. Nigel Edwards, CEO, Nuffield Trust. IHE Innovation Forum XVII – Building a Community-Based Health System: Lessons for a Path Forward
This IHE Biosimilars Invitational Forum provided the perspective of international, national, and Alberta speakers and panellists who described the biosimilar reimbursement approach taken and outcomes achieved by other jurisdictions, guiding principles and policy options for Alberta, and key performance indicators and targets for reimbursement policy going forward. Towards a Framework…
Alberta Health Services (AHS) has established a number of Strategic Clinical Networks (SCNs) in the province around specific health care topics (e.g., Cardiovascular Health & Stroke) and within areas where care is delivered (e.g., Surgery). The SCNs are the engines of innovation in the health system and have a mandate to find new and innovative ways of delivering care to provide…
This background document outlines the methods used to update the Alberta Clinical Practice Guideline (CPG) for the Evidence-Informed Primary Care Management of Low Back Pain, which was produced as part of the second phase of the Alberta Health Technology Assessment (HTA) Ambassador Program. Link to Alberta Ambassador Guideline Adaptation Program
PDF of a PowerPoint presentation by Ms. Kim Wieringa, Assistant Deputy Minister, Health Information Systems, Alberta Health. e-Health Policy Symposium – Towards “Person-Centred” Integrated Health in Alberta
PDF of a PowerPoint presentation by Dr. Doreen Rabi, Clinical Endocrinologist, Associate Professor, University of Calgary. e-Health Policy Symposium – Towards “Person-Centred” Integrated Health in Alberta
PDF of a PowerPoint presentation by Ms. Kathleen Ness, Assistant Deputy Minister, Health Service Delivery Division, Alberta Health. e-Health Policy Symposium – Towards “Person-Centred” Integrated Health in Alberta
PDF of a PowerPoint presentation by Dr. Robert Reid, Chief Scientist, Trillium Health Partners, Institute for Better Health, Mississauga, Ontario. e-Health Policy Symposium – Towards “Person-Centred” Integrated Health in Alberta
This symposium addressed the importance of integrated health information as a necessary foundation for improved patient and system outcomes. The focus of the symposium was to discuss the benefits and challenges of shared health information and to better understand the role that health care providers play individually and collectively in achieving more person-centred and integrated…
PDF of a PowerPoint presentation by Ms. Annamarie Fuchs, IMAGINE Citizens, Collaborating for Health. e-Health Policy Symposium – Towards “Person-Centred” Integrated Health in Alberta
PDF of a PowerPoint presentation by Dr. Jennifer Zelmer, President, Azimuth Health Group; Editor-in-Chief, Healthcare Policy, Toronto, Ontario. e-Health Policy Symposium – Towards “Person-Centred” Integrated Health in Alberta
The Institute of Health Economics (IHE) Life Sciences Open Innovation PlatformTM is an online “ideasourcing” platform to encourage a broad pan-Canadian community to comment on key issues and topics related to life science policy. Preliminary campaigns will focus on biosimilars policy. Ideas with the most support will be used to inform policy discourse at an IHE biosimilars…
This report provides a summary of recently published information (January 2015 to present) regarding the glucose monitoring technologies that are commercially available in North America, as well as those that are emerging within the next five years (up to 2021).